The Latest in Hypertension

Clinical Endocrinology News

AHA 2022 to recapture in-person vibe but preserve global reach

November 2, 2022

Clinical Endocrinology News

Diabetes becoming less potent risk factor for CVD events

October 19, 2022

Clinical Endocrinology News

Finerenone benefits T2D across spectrum of renal function

October 18, 2022

Clinical Endocrinology News

New deep dive into Paxlovid interactions with CVD meds

October 17, 2022

Clinical Endocrinology News

Cardiac biomarkers track with hormone therapy in transgender people

October 14, 2022

Clinical Endocrinology News

SPRINT’s intensive therapy benefit fades once BP creeps back up

October 14, 2022

Hypertension

Clinical Endocrinology News

Trial of early intensive meds at HF discharge halted for benefit: STRONG-HF

October 14, 2022

Hypertension

Clinical Endocrinology News

Dapagliflozin DELIVERs regardless of systolic pressure in HFpEF

October 11, 2022

Clinical Endocrinology News

Bariatric surgery prompts visceral fat reduction, cardiac changes

October 10, 2022

Clinical Endocrinology News

Long-term antidepressant use tied to an increase in CVD, mortality risk

October 6, 2022

Clinical Endocrinology News

Salt pills for patients with acute decompensated heart failure?

October 6, 2022

Hypertension

Clinical Endocrinology News

Newer drugs not cost effective for first-line diabetes therapy

October 6, 2022

Clinical Endocrinology News

Food insecurity a growing problem for many with CVD

October 5, 2022

Clinical Endocrinology News

How to improve diagnosis of HFpEF, common in diabetes

October 3, 2022

Clinical Endocrinology News

Heart failure drug a new treatment option for alcoholism?

September 28, 2022

Hypertension